Showing results (31-40 of 5,314) with videos related to
Sort By:
Pageof 532
Digital Health|August 25, 2022
Characteristics of Facebook's third-party medical fact checkersAlyson Haslam, Vinay PrasadJournal of the American Geriatrics Society|September 23, 2025
Age of Patients in Trials Submitted to the FDA Versus Age in Average Patients With CancerAlyson Haslam, Vinay PrasadOpen Forum Infectious Diseases|September 17, 2024
A Systematic Review of Nirmatrelvir/Ritonavir and Molnupiravir for the Treatment of Coronavirus Disease 2019Alyson Haslam, Vinay PrasadEuropean Urology Focus|April 7, 2021
Old-fashioned Intelligence Will Always Be Needed in MedicineKerrington Powell, Vinay PrasadTranslational Oncology|February 23, 2022
The approval and withdrawal of melphalan flufenamide (melflufen): Implications for the state of the FDATimothée Olivier, Vinay PrasadAmerican Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|July 5, 2015
Meta-Analyses of Statin Therapy for Primary Prevention Do Not Answer Key Questions: An Empirical Appraisal of 5 Years of Statin Meta-AnalysesChetan Huded, Vinay PrasadTranslational Oncology|July 5, 2022
Amivantamab and Mobocertinib in Exon 20 insertions EGFR Mutant Lung Cancer, Challenge To The Current GuidelinesTimothée Olivier, Vinay PrasadJAMA Network Open|July 8, 2021
Characteristics of Registered Studies of Chimeric Antigen Receptor Therapies: A Systematic ReviewRahul Banerjee, Vinay PrasadEcancermedicalscience|September 6, 2016
Negative trials in ovarian cancer: is there such a thing as too much optimism?Bishal Gyawali, Vinay PrasadJAMA Network Open|May 4, 2019
Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy DrugsAlyson Haslam, Vinay PrasadPageof 532